Cargando…
Recent advances in amyotrophic lateral sclerosis
ALS is a relentlessly progressive and fatal disease, with no curative therapies available to date. Symptomatic and palliative care, provided in a multidisciplinary context, still remains the cornerstone of ALS management. However, our understanding of the molecular mechanisms underlying the disease...
Autores principales: | Riva, Nilo, Agosta, Federica, Lunetta, Christian, Filippi, Massimo, Quattrini, Angelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893385/ https://www.ncbi.nlm.nih.gov/pubmed/27025851 http://dx.doi.org/10.1007/s00415-016-8091-6 |
Ejemplares similares
-
NEK1 Variants in a Cohort of Italian Patients With Amyotrophic Lateral Sclerosis
por: Riva, Nilo, et al.
Publicado: (2022) -
An update on the diagnosis and management of the polyneuropathy of POEMS syndrome
por: Cerri, Federica, et al.
Publicado: (2018) -
The Cortical Signature of Amyotrophic Lateral Sclerosis
por: Agosta, Federica, et al.
Publicado: (2012) -
The Peripheral Nervous System in Amyotrophic Lateral Sclerosis: Opportunities for Translational Research
por: Gentile, Francesco, et al.
Publicado: (2019) -
Current application of neurofilaments in amyotrophic lateral sclerosis and future perspectives
por: Falzone, Yuri Matteo, et al.
Publicado: (2021)